All relevant data are within the paper and its Supporting Information files.

Introduction {#sec006}
============

Ambient air pollution has an important impact on morbidity and mortality. The World Health Organization ascribed 3.7 million deaths to environmental pollution in 2012 \[[@pone.0163225.ref001]\].

In most cities, vehicular emissions represent the main source of atmospheric pollutants, and both short- and long-term exposure to traffic pollution have been associated with adverse health effects \[[@pone.0163225.ref002],[@pone.0163225.ref003]\]. Several studies \[[@pone.0163225.ref004],[@pone.0163225.ref005],[@pone.0163225.ref006]\] have shown an association between lung function decline and long-term exposure to air pollution in adults. Evidence that reduction in air pollution may improve lung function \[[@pone.0163225.ref007]\], as well as attenuate its decline with age \[[@pone.0163225.ref008]\], is also available. In an urban scenario, such as São Paulo, an individual's exposure to air pollution is highly variable and is dependent on the time spent in traffic, residence location and working conditions. Additionally, different categories of workers demand different physical activities, and the healthy worker effect cannot be assumed for all of them.

With the objective of evaluating the chronic effect of exposure to traffic-generated PM~2.5~ on lung function, we used personal monitors to collect data from outdoor workers with potentially different levels of exposure in São Paulo, Brazil. The use of personal monitors allowed a closer assessment of the actual exposure of individuals, compared with fixed stations, because it takes into account the periods of outdoor exposure times and indoor exposure times (inside the homes and workplaces) and, in this study, also inside vehicles (cabs), which have concentrations that may differ from outdoor environments and are usually lower \[[@pone.0163225.ref009],[@pone.0163225.ref010]\]. These factors were particularly important to consider for a study conducted in São Paulo, a city with 11 million inhabitants spread over an area of 1,500 Km^2^ with different and irregular traffic and topography.

Methods {#sec007}
=======

This was an observational study approved by the Ethics on Research Committee (CAPPesq) from the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (file 0565/07). All participants signed an informed consent form.

Participants {#sec008}
------------

To explore the effects of exposure variability, three categories of workers were selected. Two of the categories, that is, taxi drivers and traffic controllers, were expected to have greater exposure, whereas the third, that is, forest rangers, were presumably subjected to lower levels of exposure because they spend part of their daily life in a park in the outskirts of São Paulo. The inclusion criteria were as follows: a) working on streets and/or avenues (traffic controllers or taxi drivers) or city parks for at least two years; b) male; c) age between 18 to 65 years; and d) non-smoker or former smoker for only one year.

Initial Evaluation {#sec009}
------------------

Initial evaluation included a recording of demographic and anthropometric characteristics, confirmation of the non-smoker condition, occupational and cardiorespiratory risk assessment, as well as a clinical examination. All participants answered questions on tobacco smoke status and chronic comorbidities. Exhaled CO~2~ (ppm) was determined via a Micro CO Meter (Micro Medical Limited, Rochester, UK).

Study Protocol {#sec010}
--------------

From 2008 to 2012, the participants were scheduled in pairs to attend four visits (once a week for one month) in the Heart Institute of the University of São Paulo Medical School. During each visit, participants submitted to the following: i) an assessment of complications between the visits, ii) an evaluation of exhaled CO~2~ to confirm the non-smoking status, and iii) spirometry. At 7:00 am on the eve of each clinical evaluation, each participant received a lightweight portable battery operated sampler installed in a shoulder bag to be carried all day and kept nearby during sleeping or bathing periods to record real 24-hour environmental exposure.

Lung Function {#sec011}
-------------

Spirometry was performed in the morning with a KoKo spirometer (Pulmonary Data Services Instrumentation Inc., Louisville, USA), according to ATS/ERS recommendations \[[@pone.0163225.ref011],[@pone.0163225.ref012]\]. Three maneuvers were carried out, and the best one was chosen and analyzed according to the ATS/ERS criteria \[[@pone.0163225.ref013]\]. The values of FVC, FEV~1~ and PEF corresponded to the percentage of predicted values computed according to the reference recommended for the Brazilian population \[[@pone.0163225.ref014]\]. The values of FEV~1~/FVC as well as of the ratio FEF~25-75%~/FVC were also computed from the measured values, and those of the latter were also presented as percentages of the predicted ratio \[(FEF~25-75%~/FVC)~measured~/ (FEF~25-75%~/FVC)~predicted~\].

PM~2.5~ concentration evaluation {#sec012}
--------------------------------

The sampler, designed by the Harvard School of Public Health, operated at a flow rate of 4 L/min through an impaction plate to obtain a PM~2.5~ cutoff. A silicone catheter connected the air inlet positioned at the volunteer shoulder to the sample inflow tube. A vacuum pump powered by a rechargeable Li-Ion battery (model WR-5000 Aircheck from SKC) and equipped with a flow control and a chronometer provided the necessary continuous air flow during the 24-hour sampling period. A polycarbonate membrane \[Whatman filter with a diameter of 37 mm and 0.8 pore size (part number 110809)\], installed inside the sampler after the impaction plate retained the sampled particulate matter. This membrane was weighed before and after the sampling process with an accurate 1 μg scale (Mettler Toledo, model UMX2) following a laboratory protocol developed to control temperature and humidity \[[@pone.0163225.ref015]\], and the total mass of the collected particulate matter was estimated. The daily average concentration of PM~2.5~ was obtained by dividing the total mass by the total sampled air volume.

Exposure classification {#sec013}
-----------------------

Although high exposure was expected for taxi drivers and traffic controllers and low exposure was expected for forest rangers, an initial data analysis showed an overlap of the observed PM~2.5~ concentrations for these two groups. This is probably due to the individual monitoring of PM~2.5~ that allowed evaluation of pollutant concentrations outside the workplace, providing a more realistic measure of exposure. As the preliminary analysis suggested that the relationship between lung function variables and PM~2.5~ is not linear, the tertiles of all individual measurements of PM~2.5~ were computed, and the participants were classified into three exposure groups: low, when all measures were lower than the first tertile; high, when all measures were larger than the second tertile; and medium, otherwise. This classification ensured that all subjects in the low exposure group were always exposed to low concentrations of PM~2.5~ during the study and that those in the high exposure group were always exposed to higher concentrations of PM~2.5~.

Statistical Analysis {#sec014}
--------------------

The statistical analysis was based on the averages of the within-individual spirometric variables. Baseline covariates were accounted for in the analysis.

The means of the baseline and spirometric variables for the three groups were compared with a one-way analysis of variance. When residual diagnostic tools suggested course deviations from the model assumptions, the analysis was complemented by a Kruskal-Wallis test. To assess the association between passive smoking, respiratory symptoms, hypertension and/or diabetes and exposure to air pollution, likelihood ratio tests were considered. The association between spirometric variables and exposure, adjusted for age, waist circumference, time at their job, daily work hours, diabetes or hypertension, environmental tobacco smoke and previous smoking habits, was initially assessed using multiple linear regression fitted by least squares. A residual analysis suggested the existence of outliers and robust regression models based on MM-estimators were considered~~.~~ The models were fitted via the *lmrob* function from the *robustbase* library in the R software package (R Development Core Team 2013).

Results {#sec015}
=======

Four subjects were excluded due to inconsistencies in the pulmonary function measurements, resulting in a sample size of 101 ([S1 Table](#pone.0163225.s001){ref-type="supplementary-material"}).

Overall, 334 measures of PM~2.5~ and 320 pulmonary function tests were completed during the study period. [Fig 1](#pone.0163225.g001){ref-type="fig"} displays the distribution of all 334 individual PM~2.5~ measurements during the study period and shows the overlap of PM~2.5~ concentrations when occupational categories were considered. This overlap and the nonlinearity of the relationship between lung function variables and PM~2.5~ motivated the definition of the exposure groups regarding the PM~2.5~ tertiles, namely, 25 μg/m^3^ and 39.6 μg/m^3^.

![Dot plots of the PM~2.5~ measurements of different occupation groups during the study period.](pone.0163225.g001){#pone.0163225.g001}

Demographic and clinical characteristics {#sec016}
----------------------------------------

In [Table 1](#pone.0163225.t001){ref-type="table"}, we present summary statistics for PM~2.5~ and demographic and clinical characteristics according to the exposure groups. On average, participants in the low-exposure group had worked in the same function for a longer period and had lesser work shifts than those in the other groups.

10.1371/journal.pone.0163225.t001

###### PM~2.5~ concentration and baseline characteristics of participants (N = 101).

![](pone.0163225.t001){#pone.0163225.t001g}

                                                       Exposure groups[^(1)^](#t001fn001){ref-type="table-fn"}                                   
  ---------------------------------------------------- --------------------------------------------------------- --------------- --------------- -------------------------------------------------
  PM~2.5~                                              17.8 (±3.5)                                               36.6±(10.8)     67.4±(14.1)     \<0.001[^(2)^](#t001fn002){ref-type="table-fn"}
  Age (years)                                          46.6 (±8.4)                                               48.4 (±9.0)     49.3 (±12.4)    0.730 [^(2)^](#t001fn002){ref-type="table-fn"}
  BMI (kg/m^2^)                                        26.4 (±3.7)                                               28.9 (±4.4)     28.4 (±3.7)     0.117 [^(2)^](#t001fn002){ref-type="table-fn"}
  Waist circumference (cm)                             94.9 (±8.8)                                               102.5 (±12.7)   101.3 (±10.4)   0.098 [^(2)^](#t001fn002){ref-type="table-fn"}
  Time of work (years)                                 16.5 (±7.8)                                               10.3 (±8.2)     11.9 (±11.4)    0.041 [^(2)^](#t001fn002){ref-type="table-fn"}
  Work shift (hours)                                   9.3 (±2.4)                                                11.3 (±3.5)     12.6 (±3.5)     0.040 [^(2)^](#t001fn002){ref-type="table-fn"}
  Exhaled Carbon Monoxide (ppm)                        2.5 (±2.9)                                                2.6 (±3.1)      1.5 (±2.0)      0.525 [^(2)^](#t001fn002){ref-type="table-fn"}
  ETS[^(3)^](#t001fn003){ref-type="table-fn"} (N, %)   7 (46.7)                                                  39 (51,3)       4 (40.0)        0.775 [^(4)^](#t001fn004){ref-type="table-fn"}
   at home (N, %)                                      1 (6.7)                                                   5 (6.6)         2 (20.0)        0.430 [^(5)^](#t001fn005){ref-type="table-fn"}
   at work (N, %)                                      6 (40.0)                                                  41 (54.0)       5 (50.0)        0.610 [^(5)^](#t001fn005){ref-type="table-fn"}
  Former smoking habits (N, %)                         2 (13.3)                                                  21 (28.0)       5 (50.0)        0.135 [^(5)^](#t001fn005){ref-type="table-fn"}
  Hypertension or diabetes (N, %)                      5 (33.3%)                                                 24 (31.6%)      3 (30.0%)       0.984 [^(5)^](#t001fn005){ref-type="table-fn"}
  Hemoglobin (g/dL)                                    15.3 (±0.9)                                               15.1 (±0.9)     14.8 (±0.6)     0.463 [^(2)^](#t001fn002){ref-type="table-fn"}
  Hematocrit (%)                                       44.4 (±2.9)                                               44.7 (±2.4)     43.9 (±1.3)     0.587 [^(2)^](#t001fn002){ref-type="table-fn"}
  White blood cells (N/mm3)                            6217 (±1685)                                              6765 (±1634)    7052 (±2539)    0.469 [^(2)^](#t001fn002){ref-type="table-fn"}
  Total Cholesterol (mg/dL)                            200.1 (±39.6)                                             212.1 (±34.2)   201.8 (±34.9)   0.384 [^(2)^](#t001fn002){ref-type="table-fn"}
  HDL (mg/dL)                                          47.4 (±8.3)                                               46.2 (±12.7)    42.9 (±8.3)     0.662 [^(2)^](#t001fn002){ref-type="table-fn"}
  LDL (mg/dL)                                          130.3 (±37.6)                                             136.5 (±31.6)   132.8 (±32.2)   0.774 [^(2)^](#t001fn002){ref-type="table-fn"}
  Albumin (g/dL)                                       4.7 (±0.2)                                                4.7 (±0.2)      4.8 (±0.3)      0.623 [^(2)^](#t001fn002){ref-type="table-fn"}
  Fasting blood glucose (mg/dL)                        96.0 (±9.7)                                               101.4 (±23.4)   106.3 (±21.7)   0.510 [^(2)^](#t001fn002){ref-type="table-fn"}

^(1)^ Low: all measures of PM~2.5~ were lower than 25 μg/m^3^, High: all measures of PM~2.5~ were larger than 39.6 μg/m^3^ and Medium, otherwise;

^(2)^ ANOVA;

^(3)^ Environmental Tobacco Smoke;

^(4)^ Chi-Squared test;

^(5)^ Likelihood- Ratio test; Results expressed as the mean (± standard deviation) or number (percentage).

Lung Function {#sec017}
-------------

In [Table 2](#pone.0163225.t002){ref-type="table"}, we present descriptive statistics for the lung function data expressed in terms of percentage of the predicted value. In general, we observed a decrease in average FVC and FEV~1~ from the low exposure group to the high exposure group, although without statistical significance. On the other hand, a significant increase in FEF~25-75%~/FVC was observed, without a decrease in the FEV~1~/FVC. Box-plots for the spirometric variables are depicted in [Fig 2](#pone.0163225.g002){ref-type="fig"}.

![Box-plots of the spirometric parameters of each exposure group.\
The values of FVC and FEV~1~ correspond to the percentage of predicted values and FEF~25-75%~/FVC, and the ratio of FEV~1~/FVC was computed considering the measured values.](pone.0163225.g002){#pone.0163225.g002}

10.1371/journal.pone.0163225.t002

###### Mean (standard errors) for the spirometric data of participants and p-values for the comparison of the exposure groups (N = 101).

![](pone.0163225.t002){#pone.0163225.t002g}

                                                             Exposure groups [^(1)^](#t002fn001){ref-type="table-fn"}                                 
  ---------------------------------------------------------- ---------------------------------------------------------- -------------- -------------- ------------------------------------------------
  FVC [^(2)^](#t002fn002){ref-type="table-fn"}               94.0 (13.0)                                                94.9 (16.4)    83.5 (17.2)    0.076 [^(3)^](#t002fn003){ref-type="table-fn"}
  FEV~1~ [^(2)^](#t002fn002){ref-type="table-fn"}            91.5 (11.3)                                                91.2 (13.8)    82.2 (19.2)    0.143 [^(3)^](#t002fn003){ref-type="table-fn"}
  FEV~1~/FVC                                                 77.5 (10.9)                                                79.6 (7.3)     80.3 (6.8)     0.997 [^(3)^](#t002fn003){ref-type="table-fn"}
  FEF~25-75%~/FVC                                            82.6 (14.0)                                                84.3 (15.0)    91.0 (16.4)    0.358[^(3)^](#t002fn003){ref-type="table-fn"}
  FEF~25-75%~/FVC [^(2)^](#t002fn002){ref-type="table-fn"}   102.5 (17.1)                                               104.8 (18.3)   120.2 (22.5)   0.041 [^(3)^](#t002fn003){ref-type="table-fn"}
  PEF [^(2)^](#t002fn002){ref-type="table-fn"}               79.9 (30.0)                                                74.9 (18.5)    72.6 (26.7)    0.386 [^(3)^](#t002fn003){ref-type="table-fn"}

^(1)^ Low: all measures of PM~2.5~ were lower than 25 μg/m^3^, High: all measures of PM~2.5~ were larger than 39.6 μg/m^3^ and Medium, otherwise;

^(2)^ Percentage of predicted value;

^(3)^ Kruskal-Wallis test.

In [Table 3](#pone.0163225.t003){ref-type="table"}, we highlight the adverse effects of the level of exposure to PM~2.5~ on the spirometric parameters comparing the high and medium exposure groups to the low exposure group. To verify the robustness of the observed findings, we performed a sensitivity analysis, progressively adding more explanatory variables to check how the estimates were affected across different model specifications. The estimates of expected FVC, FEV~1~, and FEF~25-75%~/FVC remained reasonably stable for the different sets of explanatory variables considered. In the high exposure group, smaller average FVC and FEV~1~ values were observed. Additionally, in the same group, average FEF~25-75%~/FVC values were higher with no statistically significant differences detected for FEV~1~/FVC.

10.1371/journal.pone.0163225.t003

###### Effects of PM~2.5~ on lung function in different stages of the regression model fitting: high exposure---low exposure and medium exposure---low exposure.

![](pone.0163225.t003){#pone.0163225.t003g}

  Spirometric parameters (%)                                 Exposure groups compared [^(1)^](#t003fn001){ref-type="table-fn"}   Model 1   Model 2   Model 3   Model 4                                                          
  ---------------------------------------------------------- ------------------------------------------------------------------- --------- --------- --------- --------- ------ ------- -------- ------ ------- -------- ------ -------
  FVC [^(3)^](#t003fn003){ref-type="table-fn"}               Medium -Low                                                         -0.13     2.71      0.960     1.01      2.97   0.730   0.81     3.18   0.800   -0.24    3.01   0.938
                                                             High---Low                                                          -12.96    3.88      0.001     -11.01    3.98   0.007   -10.76   4.09   0.010   -12.19   3.98   0.003
  FEV~1~ [^(3)^](#t003fn003){ref-type="table-fn"}            Medium -Low                                                         0.94      3.35      0.780     1.77      3.47   0.611   1.76     3.50   0.617   1.16     3.33   0.729
                                                             High---Low                                                          -10.12    5.03      0.047     -9.36     4.52   0.041   -8.41    5.04   0.099   -9.10    5.10   0.078
  FEV~1~/FVC                                                 Medium -Low                                                         1.51      2.39      0.529     1.76      3.02   0.561   1.86     3.29   0.572   1.96     3.31   0.557
                                                             High---Low                                                          1.42      2.51      0.573     1.46      3.09   0.638   1.97     3.28   0.550   1.97     3.35   0.558
  FEF~25-75%~/FVC                                            Medium---Low                                                        1.01      3.73      0.787     -0,65     3.23   0.842   -0.78    3.22   0.808   0.049    3.38   0.989
                                                             High---Low                                                          11.02     6.18      0.073     13.01     3.91   0.001   12.29    4.53   0.008   13.34    4.55   0.004
  FEF~25-75%~/FVC [^(3)^](#t003fn003){ref-type="table-fn"}   Medium -Low                                                         1.74      3.09      0.574     -0.83     3.66   0.821   -0.80    3.79   0.833   -0.91    3.86   0.814
                                                             High---Low                                                          18.43     5.78      0.002     15.57     5.93   0.010   14.99    5.93   0.013   14.86    6.08   0.017
  PEF [^(3)^](#t003fn003){ref-type="table-fn"}               Medium -Low                                                         -4.45     5.53      0.423     -1.48     5.77   0.799   -1.76    5.82   0.763   -1.84    5.66   0.746
                                                             High---Low                                                          -6.87     7.34      0.351     -3.58     7.43   0.631   -4.34    7.99   0.588   -4.41    7.97   0.581

^(1)^ Low: all measures of PM~2.5~ were lower than μg/m^3^, High: all measures of PM~2.5~ were larger than 39.6 μg/m^3^, and Medium, otherwise;

^(2)^ Standard error;

^(3)^ Percentage of predicted value. Predictors included in the models: Model 1: exposure groups; Model 2: exposure groups + age+ waist circumference + time of work + work shift; Model 3: exposure groups + age+ waist circumference + time of work + work shift + environmental tobacco smoke at home + former smoker; Model 4: exposure groups + age+ waist circumference + time of work + work shift + environmental tobacco smoke at home + former smoker + diabetes or hypertension.

Discussion {#sec018}
==========

This study suggests a significant impairment in pulmonary function for individuals exposed to ambient levels of traffic pollution. Moreover, the results indicated that, in a complex urban scenario such as the one in São Paulo, there is a marked degree of exposure variability amongst outdoor workers. The observed findings were robust and remained reasonably stable for the different sets of explanatory variables considered.

One of the strengths of this study was the use of personal monitors to evaluate exposure to PM~2.5~, which seems more appropriate to assess daily exposure by including work shift, time while commuting and time at home \[[@pone.0163225.ref009],[@pone.0163225.ref010]\]. Assuming none or minimum changes in daily routine of participants, the air pollutant personal monitoring assessment may allow estimates of sub acute and even chronic exposures. Our results reinforced the concept that urban dwellers may experience a considerable variation of exposure, depending on their habits and work characteristics, because the difference between the means of the PM~2.5~ in the high and low exposure groups was almost 50 μg/m^3^. Monitoring personal exposure to PM~2.5~ during different weeks contributed to a perception of the most prevalent exposure profiles of the individuals. PM~2.5~ is technically easy to measure and is the pollutant most consistently associated with damage to human health. Due to its high correlation with other pollutants, it may be regarded as a proxy of a set of pollutants. An additional strength of this study is that pulmonary function was evaluated four times, yielding more reliable measures of the health-related outcomes.

Given all participants lived in São Paulo, a city known to have high levels of air pollution, a group without chronic exposure could not be included in the study. This could be considered a limitation and could suggest an underestimation of the effects of air pollution on lung function.

The three occupational categories showed only slightly different intensities of light physical activity.

The differences in exposures to PM~2.5~ seem to be the relevant cause of adverse health effects.

Most of the studies that have focused on chronic \[[@pone.0163225.ref016],[@pone.0163225.ref017],[@pone.0163225.ref018]\] or acute \[[@pone.0163225.ref017],[@pone.0163225.ref019]\] effects of air pollution suggested a reduction in pulmonary function and reported evidence of obstructive pulmonary disorder \[[@pone.0163225.ref004],[@pone.0163225.ref018]\], although this topic is still controversial \[[@pone.0163225.ref020]\]. In a recent European multicenter cohort study (ESCAPE), an association between exposure to NO~2~ and PM~10~ with reduction of FEV~1~ and FVC was observed, mainly in obese individuals. In that study, however, the mean levels of PM~10~ (25 μg/m^3^) were much lower than those observed in São Paulo (40 to 50 μg/m^3^) \[[@pone.0163225.ref021]\].

A longitudinal study carried out in Germany with women living near major roads detected a significant association between exposure to PM~10~ and reduction of FVC, FVE~1~ and FEV~1~/FVC \[[@pone.0163225.ref018]\]. A study carried out with 1,391 non-smokers followed up for 16 years \[[@pone.0163225.ref022]\] detected a decrease of 7.2% in FEV~1~ among those with higher exposure levels, as well as a significant decrease in FEV~1~/FVC.

The results of this study are in agreement with previous studies \[[@pone.0163225.ref006],[@pone.0163225.ref023]\] in the sense that air pollution is associated with a reduction in FVC and FEV~1~ without a concomitant reduction in FEV~1~/FVC. The mechanisms responsible for such alterations have not been fully identified. Animal studies \[[@pone.0163225.ref024]\], as well as autopsy studies with humans \[[@pone.0163225.ref025]\], conducted in São Paulo indicate that exposure to urban levels of air pollution promotes inflammation and structural remodeling of distal airways and centriacinar destruction of alveolar walls. A similar effect, with reduced FVC and FEV~1~, but no reduction of FEV~1~/FVC has been observed after exposure to ozone, probably due to changes in airway hysteresis compared with parenchymal hysteresis \[[@pone.0163225.ref026]\].

Recently, a cohort study involving 6,300 participants in the northeastern United States concluded that long-term exposure to PM~2.5~ was associated with lower FEV~1~ and a tendency of lower FVC, but not with a reduction in FEV~1~/FVC \[[@pone.0163225.ref027]\].

Our study also detected a significant increase in FEF~25-75%~/FVC without a corresponding reduction in FEV~1~/FVC. This can be attributed to a characteristic of fine particles that tend to deposit in the small airways, causing wall inflammation, thickening and remodeling, as suggested by studies using lungs from autopsies \[[@pone.0163225.ref028],[@pone.0163225.ref029]\]. It is not possible to exclude the possibility of a restrictive disorder. However, measurements of lung volumes are required to confirm this hypothesis.

Another possible explanation for this pattern of disturbance of respiratory function is the air trapping caused by lower airway diseases, which can promote a reduction in FVC without changes in FEV~1~/FVC, as observed in the study of people exposed to the particles generated by the attacks on the World Trade Center \[[@pone.0163225.ref030]\]. Therefore, FEF~25-75%~ may be increased in this case because it expresses the measurement of the FVC segment that represents less distal airways where the flow is faster. Due to the lack of measurements on lung volumes, diffusing capacity of the lung for carbon monoxide (D~LCO~) or impulse oscillometry, it is not possible to discriminate mechanisms related to the spirometric results.

A study carried out in India with 300 children living in an industrial area and 300 children living in a green zone estimated a prevalence of restrictive ventilatory disorders of 20.3% and 6.0%, respectively, supporting the hypothesis that exposure to air pollution may be associated with lung function impairment \[[@pone.0163225.ref023]\]. These findings are also consistent with those reported in a study involving 230 children in Mexico City and 19 in Tlaxcala; the authors detected 60% of interstitial markings in the children of Mexico City in contrast to 0% in Tlaxcala, where the PM and ozone levels are lower \[[@pone.0163225.ref031]\]. A recently published study comparing pulmonary function of healthy children across the Indian rural-urban continuum and Indian children living in the UK suggested that those living in rural areas in India have lower average values of FVC and FEV~1~, without a reduction in average FEV~1~/FVC, suggesting an association between nutritional and environmental effects and restrictive disorders because exposure to biomass in rural areas in India is common \[[@pone.0163225.ref032]\].

In one of the few studies reporting values of FEF~25-75%~, a restrictive pattern of lung function disorder very similar to that observed in our study was observed in traffic controllers in India \[[@pone.0163225.ref033]\]. However, in addition to the methodological problems of that study, this effect remains controversial given that a study conducted in the same country three years previously showed reductions in FVC and FEV~1~, but not differences in FVC/FEV~1~ and FEF~25-75%~; however, a reduction in forced inspiratory flow at 50% of inhaled volume (FIF50%) was observed among non-smoking participants \[[@pone.0163225.ref034]\]. In this study \[[@pone.0163225.ref034]\], when only smokers were taken into account, smaller values of FEF~25-75%~ and maximum voluntary ventilation among the traffic exposed participants were observed, suggesting a mixed ventilatory disorder \[[@pone.0163225.ref034]\]. It is already known that some of the people exposed to tobacco smoke develop interstitial lung disease \[[@pone.0163225.ref035],[@pone.0163225.ref036]\], which also limits the interpretation of such results.

Experimental studies in animals and humans provide biological plausibility for the association between air pollution and interstitial lung disease, involving oxidative stress, telomere shortening and inflammation mediated by transforming growth factor-β (TGF-β), as shown in a recent review \[[@pone.0163225.ref037]\].

A limitation of this study is that the number of pack years of former smokers was not assessed. Furthermore, the number of former smokers in the low and high exposure groups was very small, jeopardizing an evaluation of a possible interaction effect between previous exposure to tobacco and vulnerability due to exposure to air pollution.

In conclusion, this study indicated that adult inhabitants of a large urban center, usually exposed to higher concentrations of PM~2.5~ generated from vehicular sources, showed significant changes in lung function (reduction of FVC without changes in FEV~1~/FVC), which do not suggest an obstructive disorder. However, complementary studies are necessary to clarify the mechanisms involved in these observed functional pulmonary alterations.

What is already known on this subject? {#sec019}
--------------------------------------

-   Pulmonary function is an indicator of mortality risk.

-   Exposure to air pollutants is associated with a decline in pulmonary function.

-   Studies have shown divergent results to explain this effect and the characteristic of the impairment (restrictive or obstructive).

What this study adds? {#sec020}
---------------------

-   The environmental exposure to fine particles, generated mainly by the automotive fleet promotes a ventilatory impairment with a reduction of FVC and FEV~1~, but without changes of FEV~1~/FVC and with an increase of FEF~25-75%~.

-   These results reinforce the necessity of a more restrictive air quality standard and the implementation of a widely distributed clean public transportation system in large urban centers such as São Paulo.

Supporting Information {#sec021}
======================

###### Santos et al_PONE-D-16-01680_REV2016_05_23_Data Set.

(XLSX)
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Click here for additional data file.
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